Posted on 1/31/18
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2017 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December . . .
Posted on 1/31/18
Why Netflix Wouldn't Be a Warren Buffett Stock
Warren Buffett is regarded as the greatest investor in history, and it's clear why. The "Oracle of Omaha" has become one of the richest people in . . .
Posted on 1/31/18
resTORbio Closes IPO
BOSTON, Jan. 30, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment . . .
Posted on 1/31/18
PatientPing Announces National Collaboration with HCR ManorCare
PatientPing, a health technology company that connects providers to seamlessly coordinate patient care, today announced a new collaboration with HCR ManorCare, a leading provider of short-term, . . .
Posted on 1/31/18
Syros Announces Proposed Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company pioneering the development of medicines to control the expression of genes, today announced that it is offering . . .
Posted on 1/30/18
Biogen May Be The Only Legitimate Hope For Bringing An Alzheimer's Drug To Market
Biogen (BIIB) is currently testing its drug aducanumab in a phase 3 study treating patients with early Alzheimer's disease. That's because it and most other pharma . . .
Posted on 1/30/18
Albireo Announces Closing of $74.8 Million Public Offering
BOSTON, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today the . . .
Posted on 1/30/18
Aetna Announces Transaction with Vitality Re IX
HARTFORD, Conn.--(BUSINESS WIRE)--Aetna (NYSE: AET) today announced that it has entered into a four-year reinsurance arrangement with Vitality Re IX Limited as part of its long-term . . .
Posted on 1/30/18
Weill Cornell Medicine Joins TriNetX Health Research Network to Expand Breadth of Clinical Research
TriNetX today announced that Weill Cornell Medicine has joined the TriNetX global health research network. Weill Cornell Medicine is one of the nation's most comprehensive, integrated . . .
Posted on 1/30/18
Mercy Selects iVantage Health Analytics as Partner
NEWTON, Mass.--(BUSINESS WIRE)--iVantage Health Analytics is proud to announce its selection by Mercy as a key analytics partner for maintaining their position of continued operational and . . .
Posted on 1/30/18
Ocular Therapeutix Closes Public Offering of Common Stock
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ: OCUL) today announced the closing of its underwritten public offering of 7,475,000 shares of its common stock at a public . . .
Posted on 1/29/18
3 Small Biotechs That Big Drugmakers Are Probably Drooling Over
2018 just might be the best time to be a small biotech -- and own shares of small biotech stocks -- than ever before. Despite a . . .
Posted on 1/28/18
InVivo Therapeutics Announces Purchase Agreement for up to $15 Million with Lincoln Park Capital
InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced that it has entered into a common stock
Posted on 1/26/18
Biogen Inc. 2017 Q4 - Results - Earnings Call Slides
The following slide deck was published by Biogen Inc. in conjunction with their 2017 Q4 earnings call. 137READ FULL ARTICLE HERE
Posted on 1/26/18
Athenahealth: A Critical Update On This Battleground Stock
The Hedgeye Healthcare team sees a challenging environment for the healthcare sector in 2018. A battle is shaping up, particularly among EHR (electronic health record) companies, . . .
Posted on 1/26/18
ResTORbio Debuts IPO
BOSTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of . . .
Posted on 1/26/18
ConforMIS Prices Public Offering of Common Stock
BILLERICA, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture . . .
Posted on 1/26/18
Albireo Prices $65.0 Million Public Offering of Common Stock
BOSTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today the . . .
Posted on 1/26/18
Bain Capital-backed Solid Biosciences Rolls Out IPO
CAMBRIDGE, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ:SLDB) today announced the pricing of its initial public offering of 7,812,500 shares of its . . .
Posted on 1/25/18
Ellen M. Zane Rejoins Haemonetics Board of Directors
Haemonetics Corporation (NYSE: HAE) announced the election of Ellen M. Zane to its Board of Directors. Zane is a nationally renowned health care leader
Posted on 1/25/18
BioPharma Veterans Launch New Oncology Company
Biotech and pharmaceutical executives Robert Mulroy and Dr. Debasish Roychowdhury announced today the launch of Partner Therapeutics, or PTx, an oncology company that is focused on . . .
Posted on 1/25/18
Caresyntax Expands Footprint in South Florida Hospital Market with Med-Lab Supply Partnership
Caresyntax® Inc., a surgical risk, quality management and OR integration services company, announced today that Miami-based Med-Lab Supply, which focuses on the sales, installation and service . . .
Posted on 1/25/18
Ocular Therapeutix Prices Public Offering of Common Stock
BEDFORD, Mass--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), today announced the pricing of an underwritten public offering of 6,500,000 shares of its common stock at a public . . .
Posted on 1/25/18
Athenahealth: A Critical Update On This Battleground Stock
The Hedgeye Healthcare team sees a challenging environment for the healthcare sector in 2018. A battle is shaping up, particularly among EHR (electronic health record) companies, . . .
Posted on 1/25/18
ConforMIS Announces Proposed Public Offering of Common Stock
BILLERICA, Mass., Jan. 24, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture . . .

